Wayne Goodman, MD
Professor and Chair, Department of Psychiatry
On July 1, 2009, Dr. Goodman was appointed Professor and Chairman of the Department of Psychiatry at Icahn School of Medicine at Mount Sinai in New York City. He is the Esther and Joseph Klingenstein Professor of Psychiatry and Professor in the Department of Neuroscience.
Prior to joining Mount Sinai, he served as Director, Division of Adult Translational Research and Treatment Development (DATR), at the National Institute of Mental Health in Bethesda, Maryland from 2007-2009. He has conducted pioneering research in the field of Obsessive-Compulsive Disorder (OCD) and is the principal developer of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold standard for assessing OCD. He is co-founder of the Obsessive Compulsive Foundation, the national patient advocacy organization for this disorder.
Dr. Goodman is a native of New York City and attended the Bronx High School of Science. A graduate of Columbia University with a BS in electrical engineering, Dr. Goodman received his medical degree from Boston University and completed his internship, residency, and a research fellowship at Yale University School of Medicine where he remained on faculty until 1993 as an Associate Professor. In 1994, he joined the University of Florida in Gainesville where he served as Chairman of the Department of Psychiatry for nine years. Dr. Goodman has published more than 200 articles in scientific journals and has been principal investigator on NIMH-funded grants since 1992. He is a member of the American College of Neuropsychopharmacology, a Distinguished Fellow of the American Psychiatric Association and member of Florida's Suicide Prevention Council by gubernatorial appointment. He is the 2010 recipient of the Mysell Lecture Award from Harvard University.
As Chair of Psychiatry, Dr. Goodman works closely with the new Mount Sinai Brain Institute to conduct research on neuropsychiatric disorders such as schizophrenia, Alzheimer's disease, and bipolar disorder. Dr. Goodman is an expert psycho-pharmacologist and currently serves as Acting Chair of the Food and Drug Administration's (FDA's) Psychopharmacologic Drug Advisory Committee.